Cytek Biosciences Inc.

NASDAQ: CTKB · Real-Time Price · USD
4.03
-0.05 (-1.23%)
At close: Aug 15, 2025, 3:46 PM
4.01
-0.37%
After-hours: Aug 15, 2025, 04:04 PM EDT

Cytek Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-6.02M -12.15M 2.48M 3.03M
Depreciation & Amortization
10.49M 9.23M 5.66M 1.24M
Stock-Based Compensation
26.85M 22.05M 16.59M 6.59M
Other Working Capital
-4.2M -5.68M -4.39M 11.04M
Other Non-Cash Items
-10.77M -3.34M 2.96M 1.97M
Deferred Income Tax
-2.89M n/a n/a 448K
Change in Working Capital
7.71M -10.51M -39.93M -8.65M
Operating Cash Flow
25.38M 5.28M -12.23M 4.63M
Capital Expenditures
-3.52M -4.83M -9.87M -4.36M
Cash Acquisitions
-471K -45.13M n/a -16.63M
Purchase of Investments
-274.06M -175.94M -46.04M n/a
Sales Maturities Of Investments
195M 132M n/a n/a
Other Investing Acitivies
84K -179K -46.16M 371K
Investing Cash Flow
-82.97M -93.89M -55.91M -20.99M
Debt Repayment
3.62M -565K 2.93M n/a
Common Stock Repurchased
-21.61M -44.15M -209K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
2.17M 2.9M 2.58M 213.56M
Financial Cash Flow
-15.82M -41.81M 5.51M 213.56M
Net Cash Flow
-68.89M -131.87M -65.12M 198.5M
Free Cash Flow
21.85M 454K -22.1M 266K